Gene · 4481
Papers3,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterizing microglial gene expression in a model of secondary progressive multiple sclerosis. | Glia | 2023 | 36377669 | PubTator, text mining | PubMed |
| Characteristic submucosal alteration in biliary carcinogenesis of pancreaticobiliary maljunction with a focus on inflammasome activation. | J Hepatobiliary Pancreat Sci | 2023 | 36259178 | PubTator, text mining | PubMed |
| Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanoma. | J Pathol | 2023 | 36219477 | PubTator, text mining | PubMed |
| Identification of tumour-infiltrating myeloid subsets associated with overall survival in lung squamous cell carcinoma. | J Pathol | 2023 | 36178315 | PubTator, text mining | PubMed |
| Histamine Signaling Is Essential for Tissue Macrophage Differentiation and Suppression of Bacterial Overgrowth in the Stomach. | Cell Mol Gastroenterol Hepatol | 2023 | 36167263 | PubTator, text mining | PubMed |
| CD11b + CD43 hi Ly6C lo splenocyte-derived macrophages exacerbate liver fibrosis via spleen-liver axis. | Hepatology | 2023 | 36098707 | PubTator, text mining | PubMed |
| Dynamic alteration and prognostic significance of tumor-associated CD68+ and CD68+ PD-L1- macrophages in muscle-invasive bladder cancer treated with neoadjuvant chemotherapy. | Cancer Med | 2023 | 36043478 | PubTator, text mining | PubMed |
| Immunomodulation in age-related disorders and nanotechnology interventions. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2023 | 35950266 | PubTator, text mining | PubMed |
| KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy. | J Adv Res | 2023 | 35933091 | PubTator, text mining | PubMed |
| Macrophages as determinants and regulators of fibrosis in systemic sclerosis. | Rheumatology (Oxford) | 2023 | 35861385 | PubTator, text mining | PubMed |
| Procoagulant Activity of Blood and Microvesicles Is Disturbed by Pneumococcal Pneumolysin, Which Interacts with Coagulation Factors. | J Innate Immun | 2023 | 35843205 | PubTator, text mining | PubMed |
| Granular variant of a histiocytic tumor on the toe of a cat: Case report and literature review. | Vet Clin Pathol | 2023 | 35751153 | PubTator, text mining | PubMed |
| Regulation of cardiovascular health and disease by visceral adipose tissue-derived metabolic hormones. | J Physiol | 2023 | 35661362 | PubTator, text mining | PubMed |
| Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases. | Clin Rev Allergy Immunol | 2023 | 35031957 | PubTator, text mining | PubMed |
| Current Concepts on the Pathogenesis of Systemic Sclerosis. | Clin Rev Allergy Immunol | 2023 | 34487318 | PubTator, text mining | PubMed |
| [Establishment of a prostate cancer prognostic risk model based on the TCGA database and inflammation-related genes]. | Zhonghua Nan Ke Xue | 2022 | 37846114 | PubTator, text mining | PubMed |
| Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy. | Front Immunol | 2022 | 36755812 | PubTator, text mining | PubMed |
| Single-cell RNA-seq reveals cellular heterogeneity from deep fascia in patients with acute compartment syndrome. | Front Immunol | 2022 | 36741388 | PubTator, text mining | PubMed |
| PFKFB3 overexpression in monocytes of patients with colon but not rectal cancer programs pro-tumor macrophages and is indicative for higher risk of tumor relapse. | Front Immunol | 2022 | 36733385 | PubTator, text mining | PubMed |
| SCCPMD: Probability matrix decomposition method subject to corrected similarity constraints for inferring long non-coding RNA-disease associations. | Front Microbiol | 2022 | 36713213 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4481/papers?page=34